We are live on
!
Find out more
Voloridge Investment Management Portfolio holdings
AUM
$25B
1-Year Est. Return
28.08%
This Fund
S&P 500
This Quarter
Est. Return
+6.7%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$20.1B
AUM Growth
+$2.18B
(+12%)
Cap. Flow
+$1.44B
Cap. Flow
% of AUM
7.17%
Top 10 Holdings %
Top 10 Hldgs %
9.13%
Holding
1,701
New
303
Increased
536
Reduced
489
Closed
373
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$260M |
| 2 |
CVS Health
CVS
|
+$204M |
| 3 |
Accenture
ACN
|
+$201M |
| 4 |
Johnson & Johnson
JNJ
|
+$188M |
| 5 |
NVIDIA
NVDA
|
+$168M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$171M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$158M |
| 3 |
CME Group
CME
|
+$128M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$126M |
| 5 |
Apple
AAPL
|
+$118M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.25% |
| 2 | Healthcare | 16.53% |
| 3 | Consumer Discretionary | 13.4% |
| 4 | Industrials | 11.22% |
| 5 | Financials | 10.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
United Therapeutics
UTHR
$21.5B
| $1M | 0.01% |
+4,478
| New | +$1.1M |
|
1127
Kennametal
KMT
$2.34B
| $990K | ﹤0.01% |
35,897
-239,590
| -87% | -$6.61M |
|
|
PARA
1128
DELISTED
Paramount Global Class B
PARA
| $984K | ﹤0.01% |
+44,116
| New | +$946K |
|
1129
Petrobras Class A
PBR.A
$104B
| $980K | ﹤0.01% |
105,627
-890,057
| -89% | -$8.59M |
|
1130
Franklin Resources
BEN
$17.2B
| $970K | ﹤0.01% |
+36,007
| New | +$1.05M |
|
1131
CorVel
CRVL
$3.21B
| $970K | ﹤0.01% |
15,288
+5,274
| +53% | +$308K |
|
|
TEN
1132
Tsakos Energy Navigation Ltd
TEN
$1.23B
| $970K | ﹤0.01% |
49,901
+34,303
| +220% | +$671K |
|
1133
Green Dot
GDOT
$766M
| $955K | ﹤0.01% |
55,603
+12,442
| +29% | +$217K |
|
1134
Idexx Laboratories
IDXX
$44.2B
| $953K | ﹤0.01% |
1,906
-1,203
| -39% | -$576K |
|
1135
AbCellera Biologics
ABCL
$3.33B
| $944K | ﹤0.01% |
+125,244
| New | +$1.14M |
|
|
GOLD
1136
Gold.com Inc
GOLD
$1.28B
| $935K | ﹤0.01% |
+26,987
| New | +$897K |
|
1137
Galicia Financial Group
GGAL
$7.21B
| $926K | ﹤0.01% |
+84,297
| New | +$1.04M |
|
1138
Brady Corp
BRC
$4.45B
| $924K | ﹤0.01% |
17,198
-52,202
| -75% | -$2.73M |
|
1139
Trex
TREX
$5.08B
| $923K | ﹤0.01% |
18,956
-97,878
| -84% | -$4.95M |
|
1140
Claros Mortgage Trust
CMTG
$269M
| $920K | ﹤0.01% |
78,975
-78,885
| -50% | -$1.13M |
|
1141
McGrath RentCorp
MGRC
$2.94B
| $920K | ﹤0.01% |
9,856
-7,224
| -42% | -$714K |
|
1142
nCino
NCNO
$2.11B
| $916K | ﹤0.01% |
+36,956
| New | +$975K |
|
|
VRNT
1143
DELISTED
Verint Systems
VRNT
| $913K | ﹤0.01% |
+24,504
| New | +$914K |
|
1144
Autohome
ATHM
$2.61B
| $903K | ﹤0.01% |
26,986
-35,412
| -57% | -$1.19M |
|
1145
Triumph Financial Inc
TFIN
$1.88B
| $902K | ﹤0.01% |
15,534
-68,784
| -82% | -$3.94M |
|
1146
Axos Financial
AX
$5.75B
| $891K | ﹤0.01% |
24,121
-72,827
| -75% | -$3.14M |
|
1147
Northern Trust
NTRS
$34.8B
| $888K | ﹤0.01% |
10,078
-242,677
| -96% | -$22.5M |
|
|
PRFT
1148
DELISTED
Perficient Inc
PRFT
| $886K | ﹤0.01% |
+12,267
| New | +$896K |
|
1149
Nutrien
NTR
$32B
| $884K | ﹤0.01% |
11,976
-776,668
| -98% | -$59.9M |
|
1150
Sally Beauty Holdings
SBH
$1.55B
| $862K | ﹤0.01% |
+55,310
| New | +$860K |
|
Similar funds
VAI
JG
Voloridge Investment Management's Q1 2023 Portfolio in Review
As of Q1 2023, Voloridge Investment Management held 1,701 positions worth $20.1B, up 12% from $17.9B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Voloridge Investment Management deployed $1.44B of net new capital in Q1 2023, opening 303 new positions and adding to 536 existing holdings. Its largest new stake was NVIDIA: 7,755,630 shares worth $215M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $158M trimmed.
- Voloridge Investment Management's largest Q1 2023 buy was NVIDIA: 7,755,630 shares worth $215M.
- Voloridge Investment Management added most to UnitedHealth in Q1 2023, an estimated $260M increase.
- Voloridge Investment Management's biggest Q1 2023 reduction was Alphabet (Google) Class C, cutting an estimated $158M.
- Voloridge Investment Management fully exited Meta Platforms (Facebook) in Q1 2023, selling an estimated $171M.
- Voloridge Investment Management's ten largest holdings make up 9.1% of its $20.1B portfolio in Q1 2023.
- Voloridge Investment Management opened 303 new positions and closed 373 in Q1 2023.
- Voloridge Investment Management's portfolio value rose 12% quarter-over-quarter to $20.1B.
Based on Voloridge Investment Management's 13F filing for Q1 2023, filed 15 May 2023.